Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2013
12/18/2013EP2673264A1 Microbiocidal pyrazole derivatives
12/18/2013EP2673263A1 Novel 1-(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
12/18/2013EP2672823A1 S1p modulating agents
12/18/2013EP2672819A1 Pesticidal compositions and processes related thereto
12/18/2013EP2496557B1 Tetrahydroquinoline derivatives and their pharmaceutical use
12/18/2013EP2481730B1 Insecticidal (1,3,5)-triazinyl phenyl hydrazones
12/18/2013EP2440542B1 Substituted benzimidazoles, benzonthiazoles and benzoxazoles
12/18/2013EP2440204B1 Nicotinamide compounds useful as kinase modulators
12/18/2013EP2426109B1 Novel kinase inhibitors
12/18/2013EP2417124B1 Serotonin and norepinephrine reuptake inhibitor
12/18/2013EP2398793B1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
12/18/2013EP2150539B1 Pyridazinone derivatives
12/18/2013EP1616864B1 Quinoxaline derivatives, and organic semiconductor devices, electroluminescent devices and electronic appliances, made by using the derivatives
12/18/2013CN103459382A Heterocyclic compounds for the inhibition of pask
12/18/2013CN103459380A Novel phenylpyridine derivative and drug containing same
12/18/2013CN103459379A Glycine transport inhibitor
12/18/2013CN103450885A Organic luminescent material based on quinoxaline diamine skeleton and preparation method thereof
12/18/2013CN103450201A Preparation method of chiral 8-(3-aminopiperidine-1-yl)-xanthine
12/18/2013CN103450175A Conjugated dienes derivative and preparation method thereof and application as anti-cancer drug
12/18/2013CN103450161A Compound zhangshuhua2 and in-site synthetic method
12/18/2013CN103450160A Compound zhangshuhua1 and in-site synthetic method
12/18/2013CN103450159A Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
12/18/2013CN103450158A 2, 4 ,6 - tri-substituted pyrimidine derivative and preparing method and application thereof
12/18/2013CN103450157A Preparation method for high-purity hydroxyfasudil semihydrate
12/18/2013CN103450156A Preparation method of thalictrum faberi peimitidine
12/18/2013CN103450155A Novel synthetic technology of nicosulfuron
12/18/2013CN103450154A Double amide derivative containing sulfur ether and N-sulfur cyano (sulphone) imine structure and replacing pyrazolecarboxamide and preparing method and purpose thereof
12/18/2013CN103450153A Preparation method of anhydrous amorphous imatinib mesylate
12/18/2013CN103450152A Anti-tumor medicine in double-aryl urea structure based on indazole, indole, azaindazole or azaindole
12/18/2013CN103449945A Visible light catalyzed cross-coupling hydrogen desorption method
12/18/2013CN102659760B Extraction technology of nicotine by acid process
12/18/2013CN102300859B 1,3,5-triazine derivative, process for producing same, and organic electroluminescent element comprising same
12/18/2013CN102285971B Pyrazolyl quinazolinone compound and application thereof
12/18/2013CN102143958B Pyridazine derivatives as SMO inhibitors
12/18/2013CN101903374B 2-benzylpyridazinone derivatives as MET kinase inhibitors
12/18/2013CN101679354B Triazinedione derivatives as GABAB receptor modulators
12/18/2013CN101621998B Benzimidazole cannabinoid agonists bearing substituted heterocyclic group
12/18/2013CN101410387B Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
12/18/2013CN101014587B Substituted biaryl piperazinyl-pyridine analogues
12/17/2013US8609852 Thiazolyl mGluR5 antagonists and methods for their use
12/17/2013US8609851 Nitropyridinyl ethyleneimine compound, the pharmaceutical composition containing it, the preparation method and use thereof
12/17/2013US8609848 Pyrazolone-derivatives and their use as PDE-4 inhibitors
12/17/2013US8609842 Method for synthesizing Imatinib
12/17/2013US8609708 Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer
12/17/2013US8609700 Pyridine compounds for controlling invertebrate pests I
12/17/2013US8609699 Oxotetrahydrofuran-2-yl-benzimidazole derivative
12/17/2013US8609698 Substituted dipyridyl-dihydropyrazolones and use thereof
12/17/2013US8609696 Serotonin 5-HT2B receptor inhibitors
12/17/2013US8609686 Substituted azabicyclic compounds and the use thereof
12/17/2013US8609680 2,3-dihydro-1H-inden-1-yl-2,7-diazaspiro[3.5] nonane derivatives
12/17/2013US8609678 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
12/17/2013US8609672 Piperazinylpyrimidine analogues as protein kinase inhibitors
12/17/2013US8609662 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha. 7-nachr ligands for the treatment of CNS diseases
12/17/2013US8609650 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
12/17/2013CA2749114C Heteroatom-containing cyclic compound
12/17/2013CA2733533C Hedgehog pathway modulators
12/17/2013CA2729495C Pyrimidine derivatives as kinase inhibitors
12/17/2013CA2697051C Substituted-quinoxaline-type piperidine compounds and the uses thereof
12/17/2013CA2615751C N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof
12/17/2013CA2504401C Drug delivery systems for the prevention of neointimal hyperlasia
12/12/2013WO2013185082A2 Inhibitors of bruton's tyrosine kinase
12/12/2013WO2013184985A1 Inhibitors of influenza viruses replication
12/12/2013WO2013184934A1 Neprilysin inhibitors
12/12/2013WO2013184766A1 Compounds and compositions for modulating egfr activity
12/12/2013WO2013184757A1 Compounds and compositions for modulating egfr activity
12/12/2013WO2013184755A2 Seca inhibitors and methods of making and using thereof
12/12/2013WO2013184681A1 Crystalline forms of an androgen receptor modulator
12/12/2013WO2013184570A2 Methods for the synthesis of 1,3-substituted aminouracils and other xanthine-related compounds
12/12/2013WO2013183642A1 Axially chiral pyridine derivative or salt thereof, and method for producing same and chiral catalyst comprising same
12/12/2013WO2013183591A1 Method for producing adamantanetriol
12/12/2013WO2013182972A1 Benzimidazole-proline derivatives
12/12/2013WO2013182768A1 Salt of bicyclic aromatic anions for li-ion batteries
12/12/2013WO2013182767A1 Salt of bicyclic aromatic anions for li-ion batteries
12/12/2013WO2013182451A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
12/12/2013WO2012161071A8 Nitrogenated heterocyclic compound and agricultural or horticultural fungicide
12/12/2013US20130331578 Novel iminosugars and their applications
12/12/2013US20130331571 Glycine transporter-inhibiting substances
12/12/2013US20130331568 Acetylene derivatives having mglur 5 antagonistic activity
12/12/2013US20130331567 Modulators of atp-binding cassette transporters
12/12/2013US20130331396 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
12/12/2013US20130331391 Viral polymerase inhibitors
12/12/2013US20130331382 Pyridinone and Pyridazinone Derivatives
12/12/2013US20130331377 Diaminopyrimidine derivatives and processes for the preparation thereof
12/12/2013US20130331373 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
12/12/2013US20130331371 Azetidine Derivatives
12/12/2013US20130331370 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
12/12/2013US20130331364 Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
12/12/2013US20130330366 Neprilysin inhibitors
12/12/2013CA2876024A1 Neprilysin inhibitors
12/12/2013CA2875966A1 Compounds and compositions for modulating egfr activity
12/12/2013CA2875964A1 Seca inhibitors and methods of making and using thereof
12/12/2013CA2875767A1 Crystalline forms of an androgen receptor modulator
12/12/2013CA2875421A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
12/11/2013EP2671876A2 Pyrazine derivatives and their use as protein kinase inhbitors
12/11/2013EP2671875A1 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
12/11/2013EP2671871A1 Novel (aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications
12/11/2013EP2671870A1 Novel (aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications
12/11/2013EP2671869A1 Tetrahydroisoquinoline derivative
12/11/2013EP2671581A2 Compositions and methods for treating cancer
12/11/2013EP2670746A1 Bicyclic heteroaryl compounds as gpr119 receptor agonists
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 1080